Search Login Register

Basal Ganglia Cerebrovascular Disease Summary

Description: A pathological condition caused by impaired blood flow in the basal regions of cerebral hemispheres (BASAL GANGLIA), such as INFARCTION; HEMORRHAGE; or ISCHEMIA in vessels of this brain region including the lateral lenticulostriate arteries. Primary clinical manifestations include involuntary movements (DYSKINESIAS) and muscle weakness (HEMIPARESIS).

Also Known As: Basal Ganglia Vascular Disease; Lenticulostriate Vascular Diseases; Vascular Disease, Basal Ganglia; Vascular Diseases, Basal Ganglia; Vascular Diseases, Lenticulostriate; Lenticulostriate Vascular Disease; Lenticulostriate Vasculopathies; Vascular Disease, Lenticulostriate; Vascular Lenticulostriate Diseases; Vasculopathies, Lenticulostriate; Vasculopathy, Lenticulostriate; Cerebrovascular Disease, Basal Ganglia; Lenticulostriate Diseases, Vascular; Lenticulostriate Vasculopathy

Networked: 6 relevant articles (0 outcomes, 0 trials/studies) for this Disease

Key Drugs and Agents for Basal Ganglia Cerebrovascular Disease

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
  1. cupric sulfide (CuS) : 3 results : IBA
  2. Twin twin transfusion syndrome : 2 results : IBA
  3. Magnesium : 1 result : IBA

Diseases Related to Basal Ganglia Cerebrovascular Disease

  1. Cysts
  2. Inborn Urea Cycle Disorders
  3. Premature Obstetric Labor (Premature Labor)
  4. Hemorrhage

Key Therapies for Basal Ganglia Cerebrovascular Disease

Efficacy Chart >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.